Citations

Showing 10 of 108104 citations.

Radiographic and Clinical Outcomes of Radioscapholunate Arthrodesis in Patients With Inflammatory and Posttraumatic Arthritis
Zelenski, Nicole A. , Trentadue, Taylor P. , Moran, Steven L. , Rizzo, Marco , Trentadue, Taylor P

Mayo Clinic

HAND | February 8, 2022 | Volume: 18 | Issue: 2_suppl | Pages: 102S-110S

10.1177/15589447211058834 | PMID 35130736 Get It

Background: Radioscapholunate (RSL) fusion is performed for painful radiocarpal arthritis that is typically posttraumatic or inflammatory in nature. The purpose of this study was to determine whether patients with inflammatory conditions undergoing RSL fusion had comparable outcomes as those with posttraumatic arthritis and to determine factors impacting union. Methods: This was a retrospective review of all RSL fusions over a 25-year period. Demographic information, wrist range of motion, postoperative complications, and surgical technique, including presence or absence of resection of distal scaphoid pole, data were collected. Radiographs were examined for evidence of healing of the RSL fusion site as well as development of midcarpal arthritis. Results: Fifty-six patients underwent RSL fusion. Eight patients required revision of radiocarpal arthrodesis for painful nonunion. The fusion rate was 85.7%, and median 25 th to 75th percentile (time to healing was 4.0 3.2-5.2) months. There were no differences in time to or rate of union by inflammatory arthropathy status. Grip strength increased significantly and pain decreased significantly with surgery. Union rate was 90% with the use of K-wires, screws, or staples, which was significantly greater than plates, fusion cups, or multiple implant types. The use of autologous bone graft significantly decreased the rate of nonunion and significantly decreased time to union by 3 months compared to allograft alone. Extension was significantly improved with scaphoid distal pole resection versus without distal scaphoid pole resection. Conclusions: Radioscapholunate (RSL) fusion is an effective treatment for radiocarpal arthritis but has high nonunion rates. Fixation with K-wires, screws, or staples and use of autograft confers improved union rate.
Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning
Whiteside, Douglas M. , Basso, Michael R. , Naini, Savana M. , Porter, James N., Holker, Erin , Waldron, Eric J. , Melnik, Tanya E., Niskanen, Natalie, Whiteside, Douglas , Taylor, Sarah E.

Mayo Clinic

The Clinical Neuropsychologist | February 8, 2022 | Volume: 36 | Issue: 4 | Pages: 806-828

10.1080/13854046.2022.2030412 | PMID 35130818 Get It

18-year-old with Abdominal Pain Due to Congenital Bowel Malrotation: A Case Report
McMahon, Ellen , Penfold, Michael , Cain, Meghan, Penfold, Michael P

Mayo Clinic

Clinical Practice and Cases in Emergency Medicine | February 7, 2022 | Volume: 6 | Issue: 1 | Pages: 65-68

10.5811/cpcem.2021.11.52611 | PMID 35226849 Get It

Introduction: Congenital bowel malrotation resulting in midgut volvulus is traditionally regarded as a diagnosis of infancy. Rarely, congenital bowel malrotation is diagnosed in adolescents or adults and requires a high index of suspicion. Presentations can be acute or chronic, and physical examination findings are nonspecific. Diagnosis is primarily achieved through abdominal computed tomography (CT) or during exploratory laparotomy. The pathophysiology in late-onset malrotation is similar to neonatal malrotation, with a division of Ladd’s bands – peritoneal fibrous bands that connect the cecum to the right lower quadrant retroperitoneum – as the definitive treatment. We present a case of congenital bowel malrotation in an adolescent with persistent and worsening migratory abdominal pain. Case Report: An 18-year-old female presented to the emergency department with two days of poorly localized abdominal pain and nausea. Initial evaluation was unremarkable and she was discharged home with a diagnosis of constipation. She returned two days later with worsening abdominal pain and new onset emesis. Given her persistent and worsening symptoms an abdominal CT was performed, which revealed malrotation of the bowel. Taken together, her CT findings and abdominal symptoms were concerning for symptomatic congenital bowel malrotation and she underwent a Ladd procedure. She remained asymptomatic both at discharge and at two-week postoperative follow-up. Conclusion: Symptomatic congenital bowel malrotation is more common in older children and adults than has traditionally been thought. Physicians must consider this diagnosis in their differential when working up a patient for acute or chronic intermittent abdominal pain to prevent potentially severe sequelae.
Artificial Intelligence and the Practice of Neurology in 2035
Jones, David T. , Kerber, Kevin A., Jones, David T , Kerber, Kevin A.

Mayo Clinic

Neurology | February 7, 2022 | Volume: 98 | Issue: 6 | Pages: 238-245

10.1212/wnl.0000000000013200 | PMID 35131918 Get It

Comment: Introducing Artificial Intelligence and the Practice of Neurology in 2035
Gross, Robert A. , Jones, Lyell K , Jones, Lyell K.

Mayo Clinic

Neurology | February 7, 2022 | Volume: 98 | Issue: 6 | Pages: 237-237

10.1212/wnl.0000000000013199 | PMID 35131917 Get It

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022
Greenberg, Peter L. , Stone, Richard M. , Al‐Kali, Aref , Bennett, John M. , Borate, Uma , Brunner, Andrew M. , Chai‐Ho, Wanxing , Curtin, Peter , Castro, Carlos M. de , Deeg, H. Joachim , Dinner, Shira, Foucar, Charles , Gaensler, Karin, Garcia‐Manero, Guillermo , Keel, Sioḃán , Madanat, Yazan F. , Maness, Lori J., Mangan, James K. , McMahon, Christine M. , Patel, Bhumika J. , Sallman, David A. , Shallis, Rory M. , Shami, Paul J. , Varshavsky‐Yanovsky, Asya, Westervelt, Peter, Hollinger, Elizabeth, Shead, Dorothy A. , Hochstetler, Cindy, Madanat, Yazan , Dezern, Amy Elizabeth , Griffiths, Elizabeth A. , Head, David, Jonas, Brian A. , McCurdy, Shannon , Reddy, Vishnu , Thota, Swapna , Hollinger, Elizabeth

Mayo Clinic

Journal of the National Comprehensive Cancer Network | February 7, 2022 | Volume: 20 | Issue: 2 | Pages: 106-117

10.6004/jnccn.2022.0009 | PMID 35130502 Get It

The NCCN Guidelines for Myelodysplastic Syndromes (MDS) provide recommendations for the evaluation, diagnosis, and management of patients with MDS based on a review of clinical evidence that has led to important advances in treatment or has yielded new information on biologic factors that may have prognostic significance in MDS. The multidisciplinary panel of MDS experts meets on an annual basis to update the recommendations. These NCCN Guidelines Insights focus on some of the updates for the 2022 version of the NCCN Guidelines, which include treatment recommendations both for lower-risk and higher-risk MDS, emerging therapies, supportive care recommendations, and genetic familial high-risk assessment for hereditary myeloid malignancy predisposition syndromes.
Effect of ATP-sensitive Potassium Channel Openers on Intraocular Pressure in Ocular Hypertensive Animal Models
Chowdhury, Uttio Roy, Millar, J. Cameron , Holman, Bradley H., Anderson, Kjersten J. , Roddy, Gavin W. , Fautsch, Michael P. , Roy Chowdhury, Uttio, Dosa, Peter I.

Mayo Clinic

Investigative Opthalmology & Visual Science | February 7, 2022 | Volume: 63 | Issue: 2 | Pages: 15

10.1167/iovs.63.2.15 | PMID 35129587 Get It

Neurocognitive Screening in Patients Following SARS-CoV-2 Infection: Tools for Triage
Blackmon, Karen , Day, Gregory S. , Bosch, Wendelyn , Prabhakaran, Divya , Woolston, Dixie J., Pedraza, Otto , Powers, Harry Ross, Woolston, Dixie, Day, Gregory S , Powers, Harry Ross

Mayo Clinic

No container title available | February 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1127420/v1 | PMID 35169789 Get It

Abstract Background and purpose Cognitive complaints are common in patients recovering from Coronavirus Disease 2019 (COVID-19), yet their etiology is often unclear. We assess factors that contribute to cognitive impairment in ambulatory versus hospitalized patients during the sub-acute stage of recovery. Methods Participants were prospectively recruited from a hospital-wide registry. All patients tested positive for SARS-CoV-2 infection using a real-time reverse transcriptase polymerasechain-reaction assay. Patients ≤ 18 years-of-age and those with a pre-existing major neurocognitive disorder were excluded. Participants completed an extensive neuropsychological questionnaire and a computerized cognitive screen via remote telemedicine platform. Rates of subjective and objective neuropsychological impairment were compared between the ambulatory and hospitalized groups. Factors associated with impairment were explored separately within each group. Results A total of 102 patients (76 ambulatory, 26 hospitalized) completed the symptom inventory and neurocognitive tests 24 ± 22 days following laboratory confirmation of SARSCoV-2 infection. Hospitalized and ambulatory patients self-reported high rates of cognitive impairment (27-40%), without differences between the groups. However, hospitalized patients showed higher rates of objective impairment in visual memory (30% vs. 4%; p=0.001) and psychomotor speed (41% vs. 15%; p=0.008). Objective cognitive test performance was associated with anxiety, depression, fatigue, and pain in the ambulatory but not the hospitalized group. Conclusions Focal cognitive deficits are more common in hospitalized than ambulatory patients. Cognitive performance is associated with neuropsychiatric symptoms in ambulatory but not hospitalized patients. Objective neurocognitive measures can provide essential information to inform neurologic triage and should be included as endpoints in clinical trials.
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
D’Amico, Thomas A., Bentrem, David J. , Cooke, David T. , Corvera, Carlos U. , Das, Prajnan , Enzinger, Peter C. , Enzler, Thomas , Fanta, Paul T. , Farjah, Farhood , Gerdes, Hans, Hochwald, Steven N. , Hofstetter, Wayne L. , Ilson, David H. , Keswani, Rajesh N. , Kleinberg, Lawrence , Lacy, Jill , Ly, Quan P. , Matkowskyj, Kristina A. , McNamara, Michael J. , Mulcahy, Mary F. , Park, Haeseong , Poultsides, George A. , Reznik, Scott I. , Roses, Robert E. , Strong, Vivian E. , Su, Stacey, Wang, Hanlin L. , Wiesner, Georgia L. , Willett, Christopher G. , Yakoub, Danny , Yoon, Harry H. , McMillian, Nicole R., Pluchino, Lenora A. , Yoon, Harry, Ajani, Jaffer A. , Bentrem, David J. , Chao, Joseph , Gibson, Michael K. , Kim, Sunnie S. Y. , Klempner, Samuel J. , Outlaw, Darryl Alan , Perry, Kyle A. , Pimiento, José M.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | February 7, 2022 | Volume: 20 | Issue: 2 | Pages: 167-192

10.6004/jnccn.2022.0008 | PMID 35130500 Get It

Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type. Gastric cancer generally carries a poor prognosis because it is often diagnosed at an advanced stage. Systemic therapy can provide palliation, improved survival, and enhanced quality of life in patients with locally advanced or metastatic disease. The implementation of biomarker testing, especially analysis of HER2 status, microsatellite instability (MSI) status, and the expression of programmed death-ligand 1 (PD-L1), has had a significant impact on clinical practice and patient care. Targeted therapies including trastuzumab, nivolumab, and pembrolizumab have produced encouraging results in clinical trials for the treatment of patients with locally advanced or metastatic disease. Palliative management, which may include systemic therapy, chemoradiation, and/or best supportive care, is recommended for all patients with unresectable or metastatic cancer. Multidisciplinary team management is essential for all patients with localized gastric cancer. This selection from the NCCN Guidelines for Gastric Cancer focuses on the management of unresectable locally advanced, recurrent, or metastatic disease.
Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccination
Haralambieva, Iana H. , Monroe, Jonathon M. , Ovsyannikova, Inna G. , Grill, Diane E. , Kennedy, Richard B. , Poland, Gregory A.

Mayo Clinic

The Journal of Infectious Diseases | February 7, 2022 | Volume: 226 | Issue: 1 | Pages: 23-31

10.1093/infdis/jiac042 | PMID 35137144 Get It

Abstract The durability of protective humoral immunity after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infection is largely dependent on the generation and persistence of antigen-specific isotype-switched memory B cells (MBCs) and long-lived plasma cells that reside in the bone marrow and secrete high-affinity neutralizing antibodies. The reactivity of vaccine-induced MBCs to emerging clinically significant SARS-CoV-2 variants of concern (VoCs) is largely unknown. In a longitudinal cohort study (up to 6 months following coronavirus disease 2019 messenger RNA vaccination), we measured MBCs in concert with other functional antibody measures. We found statistically significant differences between the frequencies of MBCs responding to homologous and VoC (Beta, Gamma, and Delta) receptor-binding domains after vaccination that persisted over time. In concert with a waning antibody response, the reduced MBC response to VoCs could translate to a weaker subsequent recall immune response and increased susceptibility to the emerging SARS-CoV-2 variant strains after vaccination.